My Companies
Notification
Account
Allotted 70,00,000 fully convertible warrants at Rs196 each to promoter-group Essix Biosciences, receiving 25% upfront totalling Rs34.3 crore after 5 Aug shareholder and 16 Sep exchange approvals. Context: confirms allottee and size pending since pricing, extending recurring warrant-dilution pattern.
Ind-Swift Laboratories Targets ₹100 Crore Revenue From Jammu Upgrade By FY30
Ind-Swift Labs Approves Rs 137 Crore Preferential Warrant Issue to Promoter